• Home
    • » About Us
      • » Management

Management

Wlodek Mandecki, Ph.D.

President and Chairman

Dr. Wlodek Mandecki is President, Chairman of the Board of Directors and Chief Scientific Officer of PharmaSeq, Inc. Dr. Mandecki received a B.S. in physics from the University of Warsaw, Poland, and a Ph.D. in biochemistry from the Polish Academy of Sciences. Dr. Mandecki did his postdoctoral training at the University of California at Los Angeles, the University of Wisconsin at Madison, and the University of Colorado at Boulder. He was at Abbott Laboratories for 12 years, initially as a Group Leader and later as an R&D Manager in Corporate Molecular Biology Department, Pharmaceutical Products Division and Abbott Diagnostics Division. Recently, before founding PharmaSeq, Dr. Mandecki was Director of Molecular Biology at DGI Biotechnologies, a biotech start-up company in Edison, NJ. He is also Adjunct Professor at the Department of Microbiology and Molecular Genetics at the University of Medicine and Dentistry of New Jersey at Newark, NJ.

In addition to his accomplishments in the area of gene analysis, he has made important contributions in the area of gene regulation, expression and mutagenesis, protein structure-function, protein design and engineering, phage display and drug discovery. Dr. Mandecki has several patents and patent applications pending. He is an author of over sixty publications in peer reviewed scientific journals and has written several book chapters.

Richard G. Morris, Ph.D.

CEO

Dr. Richard Morris is Chief Executive Officer of PharmaSeq. He has over 25 years experience in the areas of biomedical instrumentation and biotechnology. Shortly after receiving his Ph.D. in biochemistry from the University of California, he began his career at Durrum Instruments (now Dionex Corp., Sunnyvale, CA). After many years of increasing responsibility at Dionex, Dr. Morris was promoted to Vice President of International Operations and was responsible for operations in Europe, Japan and China. He then became Vice President of Worldwide Sales at Molecular Dynamics (Sunnyvale, CA), where he was responsible for sales and service operations management, including subsidiaries in North America, Europe and the Pacific Rim. He then joined Sigma-Aldrich Corp. (St. Louis, MO) as President of Sigma-Aldrich Research. During his four years at this $800 million revenue division, he directed worldwide sales of catalog research products, and the organization and supervision of sales forces, marketing and associated services. In addition, he integrated multiple brands into the Research Division, created a national account strategy, instituted product management approval, and opened new markets for the company. Subsequently, he was President at CambridgeSoft Corp. (Cambridge, MA), a company specializing in desktop software solutions for chemical compound modeling.